Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02227251 |
|---|---|
| Brief Title: | Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) |
| First Submitted : | August 12, 2014 |
| First Submitted that Met QC Criteria : | August 26, 2014 |
| First Posted : | August 28, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 27, 2024 |
| Last Update Posted : | March 29, 2024 |